Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Silvia Sironi"'
Autor:
Lorenza Lazzari, Michela Pozzobon, Salomé Guillaumin, Lorenzo Rosso, Enrico Ragni, Silvia Sironi, Mario Barilani, Francesca Polveraccio, Federica Banfi, Monica Moro, Giuseppe Astori
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports
Scientific Reports
Human multipotent mesenchymal stromal cells (MSC) are isolated from a plethora of tissue sources for cell therapy purposes. In 2006, the International Society for Cellular Therapy (ISCT) published minimal guidelines to define MSC identity. Neverthele
Autor:
Francesco Barretta, Luca Ferrari, Silvia Sironi, Valentina Bollati, Marco Vicenzi, Andrea A. Baccarelli, Marco Guazzi, Letizia Tarantini
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 16, Iss 14, p 2530 (2019)
International Journal of Environmental Research and Public Health
Volume 16
Issue 14
International Journal of Environmental Research and Public Health
Volume 16
Issue 14
Essential hypertension is the leading preventable cause of death in the world. Epidemiological studies have shown that physical training can reduce blood pressure (BP), both in hypertensive and healthy individuals. Increasing evidence is emerging tha
Autor:
Heidrun Drolle, Karsten Spiekermann, Michael Fiegl, Silvia Sironi, Harald Polzer, Michaela Wagner, Christina Rieger, Alexander Kuett
Publikováno v:
Sci. Rep. 5:17550 (2015)
Scientific Reports
Scientific Reports
Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase constitutively expressed by acute myeloid leukaemia (AML) blasts. In addition, 25% of AML patients harbour a FLT3-ITD mutation, associated with inferior outcome due to increased relapse
Autor:
Jochen Vasold, Michaela Wagner, Alexander Kütt, Heidrun Drolle, Tobias Herold, Silvia Sironi, Karl Sotlar, Christian Deniffel, Michael Fiegl, Christina Rieger
Publikováno v:
Leukemia research. 39(7)
Reduced oxygen partial pressure (pO2, hypoxia) is an important component of the bone marrow microenvironment and the hematopoietic stem cell niche. It is unclear whether this applies to the leukemic stem cell as well and if differences in pO2 between
Autor:
Michael Fiegl, Heidrun Drolle, Jochen Vasold, Christian Deniffel, Silvia Sironi, Michaela Wagner, Robert A.J. Oostendorp, Alexander Kütt, Christina Rieger
Publikováno v:
Leukemia research. 39(2)
Immune therapy for acute myeloid leukaemia (AML) has been largely disappointing. One possible explanation might lie in the microenvironment of the bone marrow, comprising cellular (e.g. mesenchymal stromal cells, MSC) and non-cellular components (e.g